Home-Based parenting program aims to strengthen bonds for mothers in recovery

NCT ID NCT03866694

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests a home-based parenting program called BRIGHT for pregnant women receiving treatment for opioid use disorder. The program starts in the third trimester and continues for six months after birth, focusing on the parent-child relationship, mental health, and infant development. Half of the 60 participants receive BRIGHT plus standard care; the other half receive only handouts and standard care. Researchers will measure changes in parent-child interaction and parenting attitudes to see if the program reduces the risk of child maltreatment and improves family well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a home-based therapeutic parenting intervention called BRIGHT, plus monthly handouts and standard care
What this could lead to
If effective, this program could provide a scalable way to support mothers in recovery and improve outcomes for their infants.
What could go wrong
This is a small early-stage trial with 60 participants, so results may not apply broadly. The intervention is behavioral and effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Medical Center

    Boston, Massachusetts, 02118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.